Welcome!
Welcome to the new CancerGRACE.org! Explore our fresh look and improved features—take a quick tour to see what’s new.
Article and Video CATEGORIES
Buddy is a strategic thought leader in new media technologies with 16+ years of digital content strategy experience. He has written and spoken extensively about healthcare marketing, social networks, marketing storytelling, web technologies and multimedia. He is the author of five mass market books on content, creative techniques, and process. He launched and maintained award-winning health information websites and was one of the driving forces behind placing the first pharmaceutical brand on a social network.
Dr. Jack West – Social Media in Healthcare
dbrock
Image
Buddy Scalera is a podcaster and Senior Director of Content Strategy in Global Health Science at the Medicines Company, and has been a member of the GRACE board of directors since 2011. We are thankful to Buddy for his ongoing input to GRACE, and allowing us to share this interview with GRACE founder and president Jack West, MD. 
Recently Dr. Jack West made a special guest appearance on RxDM Storycast, with Buddy Scalera. In this interview on the RX Digital Marketing Podcast, Dr. West discusses GRACE and topics related to storytelling in healthcare, the role of social media in healthcare, and the ways that the pharmaceutical industry can work effectively with non-government organizations.
The full one-hour audio podcast and full transcript are available for free at the RXDigitalMarketing.com website, available here, or clicking the image below.
“I think that oncologists and physicians, in general, have become enamored of statistics and evidence-based medicine, and of course that is really, has been in many ways, a benefit in the sophisticated way we think about treating patients,” explains Dr. West in the podcast, “but lost is the fact that everybody’s brain is really equipped best to think about narratives, about stories.”
The RX Digital Marketing podcast covers a wide range of topics, including ways that patients and professionals leverage social media for support. Dr. West spoke about early social networks during his TEDx talk in 2011. Buddy Scalera and Dr. West review key points from that presentation, as well. Dr. West’s TEDx talk can be viewed here.
|
About Buddy Scalera Senior Director, Content Strategy Buddy is a strategic thought leader in new media technologies with 16+ years of digital content strategy experience. He has written and spoken extensively about healthcare marketing, social networks, marketing storytelling, web technologies and multimedia. He is the author of five mass market books on content, creative techniques, and process. He launched and maintained award-winning health information websites and was one of the driving forces behind placing the first pharmaceutical brand on a social network. At The Medicines Company, Buddy is the Senior Director of Content Strategy in the Global Health Sciences division. Twitter: @BuddyScalera Website: BuddyScalera.com |
Video Language
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Image
Video
In this series, the 2024-25 Clinical Trials Experiences Through Storytelling Program, we talk to cancer survivors who have a passion for telling their stories in order to help others who may be navigating the clinical trials experience.
In this 2nd series of videos, Michael Herman takes us through the story of his diagnosis, his struggles with treatment options, his clinical trial and his learning curve.
Thank you to our Sponsors! #lilly #exelixis
Image
Video
In this series, the 2024-25 Clinical Trials Experiences Through Storytelling Program, we talk to cancer survivors who have a passion for telling their stories in order to help others who may be navigating the clinical trials experience.
Image
Article
Tell your story and help us help others! Apply online now for this paid opportunity. This program gives a voice to those who have experience in participating in a clinical trial for a cancer diagnosis. Your voice helps to educate and advocate for others who are in or who may be considering a clinical trial. We want to hear from you!
Online Community
A Brief Tornado. I love the analogy Dr. Antonoff gave us to describe her presentation. I felt it earlier too and am looking forward to going back for deeper dive.
Dr. Singhi's reprise on appropriate treatment, "Right patient, right time, right team".
While Dr. Ryckman described radiation oncology as "the perfect blend of nerd skills and empathy".
I hope any...
My understanding of ADCs is very basic. I plan to study Dr. Rous’ discussion to broaden that understanding.
Here's the webinar on YouTube. It begins with the agenda. Note the link is a playlist, which will be populated with shorts from the webinar on specific topics
An antibody–drug conjugate (ADC) works a bit like a Trojan horse. It has three main components:
- The antibody, which serves as the “horse,” specifically targets a protein found on cancer...
Bispecifics, or bispecific antibodies, are advanced immunotherapy drugs engineered to have two binding sites, allowing them to latch onto two different targets simultaneously, like a cancer cell and a T-cell, effectively...